Inclusive of all taxes
Glibenclamide & Metformin Sustained Release Tablets are a high-quality pharmaceutical formulation designed specifically for the efficient management of diabetes mellitus. This dual-action medication combines the glucose-lowering effects of Glibenclamide, a sulfonylurea class drug, with Metformin, an insulin sensitizer, in a sustained release tablet form. Engineered for consistent therapeutic efficacy, these tablets offer extended drug release, allowing better glycemic control with reduced dosing frequency. Manufactured in WHO-GMP certified facilities under stringent export quality standards, the formulation ensures precise dosage accuracy, safety, and compliance with international pharmacopoeial norms (IP/USP). Packaged in export-grade blister or strip packs, these tablets are ideal for global markets including regulated and semi-regulated countries. The sustained release mechanism enhances patient adherence by minimizing side effects often associated with immediate-release formulations and maintaining stable plasma drug concentrations. Suitable for institutional buyers, pharmaceutical distributors, and healthcare providers, this product supports clinical management of Type 2 diabetes with proven reliability and quality assurance.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Glibenclamide and Metformin |
| Formulation Type | Sustained Release Tablets |
| Indication | Management of Type 2 Diabetes Mellitus |
| Dosage Accuracy | Precise and consistent dosing per tablet |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Quality Compliance | IP/USP pharmacopoeial standards adherence |
| Packaging | Export-grade blister or strip packs |
| Shelf Life | As per regulatory standards |
| Export Suitability | Compliant with international market requirements |
| Therapeutic Benefits | Improved glycemic control with extended drug release |
| Attributes | Description |
|---|---|
| Category | Diabetes Medication |
| Dosage Form | Tablet |
| Drug Release Mechanism | Sustained/Extended Release |
| Manufacturer | IndiGlobal Exports |
| Intended Use | Type 2 Diabetes Treatment |
| Regulatory Compliance | WHO-GMP, IP, USP |
| Packaging Type | Export-quality blister/strip packs |
| Storage Requirements | Store in a cool, dry place away from direct sunlight |
| Batch Testing | Each batch undergoes rigorous quality control checks |
| Market Target | International pharmaceutical markets |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The sustained release formulation ensures controlled and gradual release of active ingredients, improving glycemic control, reducing dosing frequency, and minimizing side effects typically linked with immediate-release versions.
Yes, these tablets are manufactured in WHO-GMP compliant facilities and comply with IP/USP standards, making them fully suitable for export to regulated and semi-regulated international markets.
The tablets come in export-grade blister or strip packs designed for secure distribution and bulk order requirements typical of institutional buyers and pharmaceutical distributors.
Combining Glibenclamide, which stimulates insulin secretion, with Metformin, which enhances insulin sensitivity, offers a synergistic effect for better blood glucose regulation.
Each batch undergoes rigorous quality checks including dosage accuracy, purity, and safety tests, ensuring consistent therapeutic efficacy and regulatory compliance.
Brand: indiglobal exports
Country Of Origin: India
Glibenclamide & Metformin Sustained Release Tablets is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Glibenclamide & Metformin Sustained Release Tablets is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
